Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001140361-21-015352
Filing Date
2021-04-30
Accepted
2021-04-30 17:11:52
Documents
5
Period of Report
2021-03-25
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A brhc10023628_8ka.htm 8-K/A 26374
2 EXHIBIT 23.1 brhc10023628_ex23-1.htm EX-23.1 2480
3 EXHIBIT 99.1 brhc10023628_ex99-1.htm EX-99.1 433184
4 EXHIBIT 99.2 brhc10023628_ex99-2.htm EX-99.2 495044
5 EXHIBIT 99.3 brhc10023628_ex99-3.htm EX-99.3 646877
  Complete submission text file 0001140361-21-015352.txt   1605351
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-11460 | Film No.: 21879607
SIC: 2834 Pharmaceutical Preparations